Hemab Therapeutics

Hemab Therapeutics is a biotech company in Cambridge, founded in 2019. It has raised $347.0M across 3 rounds, most recently a $157.0M Series C in March 2026.

Hemab - A bleeding disorder company

Headquarters
Cambridge
Employees
11–50
Founded
2019
Business Model
B2B
Website
hemab.com
Total Funding
$347.0M
Last Round
$157.0M Series CMar 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 9 investors for this company. The full record is or through the API.

About

Hemab Therapeutics is a clinical-stage biopharmaceutical company developing novel prophylactic therapies for serious, underserved bleeding and thrombotic disorders. Its lead program, sutacimig, is a bispecific antibody in Phase 2 trials for Glanzmann Thrombasthenia, and HMB-002 targets Von Willebrand Disease. Founded in 2019 by former Novo Nordisk researchers and backed by Novo Holdings, the company is advancing a pipeline aimed at enabling prevention rather than just management of rare bleeding conditions.

Summary

It lists 11–50 employees. It has raised $347.0M in total across 3 rounds, most recently a $157.0M Series C round in Mar 2026. Investors include Sofinnova Partners, Access Industries and Novo Holdings A/S.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CMar 2026
$157.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hemab Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/hemab-therapeutics"><img src="https://indexed.vc/api/badge/company/hemab-therapeutics" alt="Hemab Therapeutics on Indexed.vc" width="260" height="76" /></a>